Design attributes of long-circulating polymeric drug delivery vehicles

被引:46
作者
Beck-Broichsitter, Moritz [1 ]
Nicolas, Julien [1 ]
Couvreur, Patrick [1 ]
机构
[1] Univ Paris Sud, Fac Pharmacie, Inst Galien UMR CNRS 8612, F-92296 Chatenay Malabry, France
关键词
Accelerated blood clearance; Biodegradable nanoparticles; Complement activation; Controlled drug delivery; Enhanced permeability and retention; Mononuclear phagocyte system; Particle shape; PEGylation; Plasma protein adsorption; Targeting; ACCELERATED BLOOD CLEARANCE; SELF-ASSEMBLED MONOLAYERS; RADICAL EMULSION POLYMERIZATION; COMPLEMENT-SYSTEM ACTIVATION; PROTEIN SURFACE INTERACTIONS; ADSORBED PLASMA-PROTEINS; POLYETHYLENE-GLYCOL PEG; CELLULAR INTERNALIZATION; POLY(ETHYLENE GLYCOL); PARTICLE-SIZE;
D O I
10.1016/j.ejpb.2015.03.033
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Following systemic administration polymeric drug delivery vehicles allow for a controlled and targeted release of the encapsulated medication at the desired site of action. For an elevated and organ specific accumulation of their cargo, nanocarriers need to avoid opsonization, activation of the complement system and uptake by macrophages of the mononuclear phagocyte system. In this respect, camouflaged vehicles revealed a delayed elimination from systemic circulation and an improved target organ deposition. For instance, a steric shielding of the carrier surface by poly(ethylene glycol) substantially decreased interactions with the biological environment. However, recent studies disclosed possible deficits of this approach, where most notably, poly(ethylene glycol)-modified drug delivery vehicles caused significant immune responses. At present, identification of novel potential carrier coating strategies facilitating negligible immune reactions is an emerging field of interest in drug delivery research. Moreover, physical carrier properties including geometry and elasticity seem to be very promising design attributes to surpass numerous biological barriers, in order to improve the efficacy of the delivered medication. (C) 2015 Elsevier B.V. All rights reserved.
引用
收藏
页码:304 / 317
页数:14
相关论文
共 336 条
[61]  
Choi HS, 2010, NAT NANOTECHNOL, V5, P42, DOI [10.1038/nnano.2009.314, 10.1038/NNANO.2009.314]
[62]  
CHONN A, 1991, J IMMUNOL, V146, P4234
[63]   Lysosomal enzyme trafficking between phagosomes, endosomes, and lysosomes in J774 macrophages - Enrichment of cathepsin H in early endosomes [J].
Claus, V ;
Jahraus, A ;
Tjelle, T ;
Berg, T ;
Kirschke, H ;
Faulstich, H ;
Griffiths, G .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (16) :9842-9851
[64]   Biologically Responsive Polymeric Nanoparticles for Drug Delivery [J].
Colson, Yolonda L. ;
Grinstaff, Mark W. .
ADVANCED MATERIALS, 2012, 24 (28) :3878-3886
[65]   Nanoparticles in drug delivery: Past, present and future [J].
Couvreur, P. .
ADVANCED DRUG DELIVERY REVIEWS, 2013, 65 (01) :21-23
[66]   POLYCYANOACRYLATE NANOCAPSULES AS POTENTIAL LYSOSOMOTROPIC CARRIERS - PREPARATION, MORPHOLOGICAL AND SORPTIVE PROPERTIES [J].
COUVREUR, P ;
KANTE, B ;
ROLAND, M ;
GUIOT, P ;
BAUDUIN, P ;
SPEISER, P .
JOURNAL OF PHARMACY AND PHARMACOLOGY, 1979, 31 (05) :331-332
[67]   Nanotechnology: Intelligent design to treat complex disease [J].
Couvreur, Patrick ;
Vauthier, Christine .
PHARMACEUTICAL RESEARCH, 2006, 23 (07) :1417-1450
[68]   Towards more effective advanced drug delivery systems [J].
Crommelin, Daan J. A. ;
Florence, Alexander T. .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2013, 454 (01) :496-511
[69]   Super-Soft Hydrogel Particles with Tunable Elasticity in a Microfluidic Blood Capillary Model [J].
Cui, Jiwei ;
Bjoernmalm, Mattias ;
Liang, Kang ;
Xu, Chenglong ;
Best, James P. ;
Zhang, Xuehua ;
Caruso, Frank .
ADVANCED MATERIALS, 2014, 26 (43) :7295-7299
[70]   Optimization of cell receptor-specific targeting through multivalent surface decoration of polymeric nanocarriers [J].
D'Addio, Suzanne M. ;
Baldassano, Steven ;
Shi, Lei ;
Cheung, Lila ;
Adamson, Douglas H. ;
Bruzek, Matthew ;
Anthony, John E. ;
Laskin, Debra L. ;
Sinko, Patrick J. ;
Prud'homme, Robert K. .
JOURNAL OF CONTROLLED RELEASE, 2013, 168 (01) :41-49